ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?
Endoscopic Retrograde Cholangiopancreatography (ERCP)-Induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?
Sponsor: University Hospital Rijeka
Listed as NCT02602574, this observational or N/A phase trial focuses on Post-ERCP Acute Pancreatitis and remains ongoing. Sponsored by University Hospital Rijeka, it has been updated 15 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jun 2022 [monthly]
Enrolling By Invitation
▶ Show 10 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Nov 2020 — Dec 2020 [monthly]
Enrolling By Invitation
-
Jun 2019 — Nov 2020 [monthly]
Enrolling By Invitation
-
Jun 2018 — Jun 2019 [monthly]
Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
-
Jun 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Jun 2017 [monthly]
Enrolling By Invitation NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital Rijeka
For direct contact, visit the study record on ClinicalTrials.gov .